Upgrade to SI Premium - Free Trial

Avidity Biosciences Inc. (RNA)

12.17 -0.12 (0.98%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/2/26)
- M&A (3/31/15 *Est)

Latest Headlines

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 20, 2026 5:58 PM - PR NewsWire FDA clears Atrium Therapeutics IND for rare heart disease drug July 14, 2026 6:30 AM - StreetInsider Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome July 14, 2026 6:30 AM - PR NewsWire Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 23, 2026 4:05 PM - PR NewsWire Cantor Fitzgerald Starts Atrium Therapeutics (RNA) at Neutral June 18, 2026 6:07 AM - StreetInsider Leerink Partners Starts Atrium Therapeutics (RNA) at Outperform May 15, 2026 6:08 AM - StreetInsider Atrium Therapeutics Reports First Quarter 2026 Financial Results May 14, 2026 4:40 PM - PR NewsWire Full Article List